Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases

被引：12
|
作者：
Stefan, Norbert [1 ,2 ]
Lonardo, Amedeo [3 ]
Targher, Giovanni [4 ,5 ]
机构：
[1] Univ Tubingen, Dept Internal Med 4, Div Endocrinol Diabetol & Nephrol, Tubingen, Germany
[2] Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis IDM, Tubingen, Germany
[3] Azienda Osped Univ Modena, Dept Internal Med, Modena, Italy
[4] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy
[5] IRCCS Sacro Cuore Don Calabria Hosp, Metab Dis Res Unit, Verona, Italy
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2024年 / 21卷 / 03期
关键词：
D O I：
10.1038/s41575-023-00880-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and chronic kidney disease. Successful treatment of steatotic liver disease might also be effective in preventing these cardiometabolic diseases.
引用
收藏
页码：136 / 137
页数：2
相关论文
共 50 条
  • [11] The role of past and present alcohol use in steatotic liver disease
    Aberg, Fredrik
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (03): : 188 - 189
  • [12] Cardiometabolic phenotype linked to fibrosis and mortality in metabolic dysfunction-associated steatotic liver disease
    Dong, Rui
    Tian, Ting
    Luo, Zhenghan
    Chang, Dongchun
    Xue, Hong
    Qu, Sen
    Wang, Jia
    Shen, Chao
    Zhang, Ru
    Wang, Jie
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (03)
  • [13] THE ROLE OF MICRORNA 122 IN METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE
    Tran, Khang
    Devaskar, Sherin
    Ghosh, Shubhamoy
    Calkins, Kara
    HEPATOLOGY, 2024, 80 : S88 - S89
  • [14] Functional foods and cardiometabolic diseases International Task Force for Prevention of Cardiometabolic Diseases
    Assmann, G.
    Buono, P.
    Daniele, A.
    Della Valle, E.
    Farinaro, E.
    Ferns, G.
    Krogh, V.
    Kromhout, D.
    Masana, L.
    Merino, J.
    Misciagna, G.
    Panico, S.
    Riccardi, G.
    Rivellese, A. A.
    Rozza, F.
    Salvatore, F.
    Salvatore, V.
    Stranges, S.
    Trevisan, M.
    Trimarco, B.
    Vetrani, C.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2014, 24 (12) : 1272 - 1300
  • [15] The role of Andrographolide in the prevention and treatment of liver diseases
    Qin, Xiaoyan
    Wang, Xi
    Tian, Maoying
    Dong, Zhaowei
    Wang, Jin
    Wang, Chao
    Huang, Qinwan
    PHYTOMEDICINE, 2023, 109
  • [16] Bile Acids as Emerging Players at the Intersection of Steatotic Liver Disease and Cardiovascular Diseases
    Bilson, Josh
    Scorletti, Eleonora
    Swann, Jonathan R.
    Byrne, Christopher D.
    BIOMOLECULES, 2024, 14 (07)
  • [17] Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents
    Zheng, Xiaoyan
    Zhao, Dongying
    Wang, Liwei
    Wang, Yiwen
    Chen, Yan
    Zhang, Yongjun
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [18] Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Polyzos, Stergios A.
    Targher, Giovanni
    CURRENT OBESITY REPORTS, 2024, 13 (02) : 242 - 255
  • [19] The steatotic liver disease burden paradox: unravelling the key role of alcohol
    Torp, Nikolaj
    Israelsen, Mads
    Krag, Aleksander
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, : 281 - 292
  • [20] The promising role of Transcendental Meditation in the prevention and treatment of cardiometabolic diseases: A systematic review
    Khanal, Mahesh Kumar
    Karimi, Leila
    Saunders, Peter
    Schneider, Robert H.
    Salerno, John
    Livesay, Karen
    Hallam, Karen T.
    de Courten, Barbora
    OBESITY REVIEWS, 2024, 25 (10)
12345